What SAKAK does
SAKAK develops HyPAA (Hyper-Personalized AI Agent), an on-device AI system that continuously learns from a user's personal data to support customized tasks, and offers healthcare-specific APIs for building tailored AI services. Founded in Seoul in April 2022, the company is applying the technology to insurance and healthcare business lines. SAKAK raised a Series A round from Uanta Investment and the Korea Credit Guarantee Fund, announced around July 2, 2026, with investors citing the commercial potential of HyPAA, per Etnews. The company was also selected for Gwangju Creative Economy Innovation Center's 2026 deep-tech startup scale-up program.
SAKAK is a healthcare tool on Falcoscan. On-device hyper-personalized AI agents for insurance and healthcare. Falcoscan rates SAKAK with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: hot. SAKAK is founded in 2022, currently at Series_a stage. Pricing: Paid.